Global Fluidics for Preclinical Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Fluidics for Preclinical Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Software and Accessories
1.3.3 Precision Syringe Pumps
1.4 Market by Application
1.4.1 Global Fluidics for Preclinical Market Share by Application: 2020 VS 2026
1.4.2 Clinica
1.4.3 Research
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fluidics for Preclinical Market Perspective (2015-2026)
2.2 Fluidics for Preclinical Growth Trends by Regions
2.2.1 Fluidics for Preclinical Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Fluidics for Preclinical Historic Market Share by Regions (2015-2020)
2.2.3 Fluidics for Preclinical Forecasted Market Size by Regions (2021-2026)
2.3 Fluidics for Preclinical Industry Dynamic
2.3.1 Fluidics for Preclinical Market Trends
2.3.2 Fluidics for Preclinical Market Drivers
2.3.3 Fluidics for Preclinical Market Challenges
2.3.4 Fluidics for Preclinical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fluidics for Preclinical Players by Market Size
3.1.1 Global Top Fluidics for Preclinical Players by Revenue (2015-2020)
3.1.2 Global Fluidics for Preclinical Revenue Market Share by Players (2015-2020)
3.2 Global Fluidics for Preclinical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fluidics for Preclinical Revenue
3.4 Global Fluidics for Preclinical Market Concentration Ratio
3.4.1 Global Fluidics for Preclinical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fluidics for Preclinical Revenue in 2019
3.5 Key Players Fluidics for Preclinical Area Served
3.6 Key Players Fluidics for Preclinical Product Solution and Service
3.7 Date of Enter into Fluidics for Preclinical Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fluidics for Preclinical Breakdown Data by Type
4.1 Global Fluidics for Preclinical Historic Market Size by Type (2015-2020)
4.2 Global Fluidics for Preclinical Forecasted Market Size by Type (2021-2026)
5 Fluidics for Preclinical Breakdown Data by Application
5.1 Global Fluidics for Preclinical Historic Market Size by Application (2015-2020)
5.2 Global Fluidics for Preclinical Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Fluidics for Preclinical Market Size (2015-2026)
6.2 North America Fluidics for Preclinical Market Size by Type (2015-2020)
6.3 North America Fluidics for Preclinical Market Size by Application (2015-2020)
6.4 North America Fluidics for Preclinical Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Fluidics for Preclinical Market Size (2015-2026)
7.2 Europe Fluidics for Preclinical Market Size by Type (2015-2020)
7.3 Europe Fluidics for Preclinical Market Size by Application (2015-2020)
7.4 Europe Fluidics for Preclinical Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Fluidics for Preclinical Market Size (2015-2026)
8.2 Asia-Pacific Fluidics for Preclinical Market Size by Type (2015-2020)
8.3 Asia-Pacific Fluidics for Preclinical Market Size by Application (2015-2020)
8.4 Asia-Pacific Fluidics for Preclinical Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Fluidics for Preclinical Market Size (2015-2026)
9.2 Latin America Fluidics for Preclinical Market Size by Type (2015-2020)
9.3 Latin America Fluidics for Preclinical Market Size by Application (2015-2020)
9.4 Latin America Fluidics for Preclinical Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fluidics for Preclinical Market Size (2015-2026)
10.2 Middle East & Africa Fluidics for Preclinical Market Size by Type (2015-2020)
10.3 Middle East & Africa Fluidics for Preclinical Market Size by Application (2015-2020)
10.4 Middle East & Africa Fluidics for Preclinical Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 AMETEK Inc
11.1.1 AMETEK Inc Company Details
11.1.2 AMETEK Inc Business Overview
11.1.3 AMETEK Inc Fluidics for Preclinical Introduction
11.1.4 AMETEK Inc Revenue in Fluidics for Preclinical Business (2015-2020))
11.1.5 AMETEK Inc Recent Development
11.2 Blacktrace Holdings Ltd
11.2.1 Blacktrace Holdings Ltd Company Details
11.2.2 Blacktrace Holdings Ltd Business Overview
11.2.3 Blacktrace Holdings Ltd Fluidics for Preclinical Introduction
11.2.4 Blacktrace Holdings Ltd Revenue in Fluidics for Preclinical Business (2015-2020)
11.2.5 Blacktrace Holdings Ltd Recent Development
11.3 Fluigent SA
11.3.1 Fluigent SA Company Details
11.3.2 Fluigent SA Business Overview
11.3.3 Fluigent SA Fluidics for Preclinical Introduction
11.3.4 Fluigent SA Revenue in Fluidics for Preclinical Business (2015-2020)
11.3.5 Fluigent SA Recent Development
11.4 Halma Plc
11.4.1 Halma Plc Company Details
11.4.2 Halma Plc Business Overview
11.4.3 Halma Plc Fluidics for Preclinical Introduction
11.4.4 Halma Plc Revenue in Fluidics for Preclinical Business (2015-2020)
11.4.5 Halma Plc Recent Development
11.5 Harvard Bioscience Inc
11.5.1 Harvard Bioscience Inc Company Details
11.5.2 Harvard Bioscience Inc Business Overview
11.5.3 Harvard Bioscience Inc Fluidics for Preclinical Introduction
11.5.4 Harvard Bioscience Inc Revenue in Fluidics for Preclinical Business (2015-2020)
11.5.5 Harvard Bioscience Inc Recent Development
11.6 IDEX Corp
11.6.1 IDEX Corp Company Details
11.6.2 IDEX Corp Business Overview
11.6.3 IDEX Corp Fluidics for Preclinical Introduction
11.6.4 IDEX Corp Revenue in Fluidics for Preclinical Business (2015-2020)
11.6.5 IDEX Corp Recent Development
11.7 IMI Plc
11.7.1 IMI Plc Company Details
11.7.2 IMI Plc Business Overview
11.7.3 IMI Plc Fluidics for Preclinical Introduction
11.7.4 IMI Plc Revenue in Fluidics for Preclinical Business (2015-2020)
11.7.5 IMI Plc Recent Development
11.8 M Dialysis AB
11.8.1 M Dialysis AB Company Details
11.8.2 M Dialysis AB Business Overview
11.8.3 M Dialysis AB Fluidics for Preclinical Introduction
11.8.4 M Dialysis AB Revenue in Fluidics for Preclinical Business (2015-2020)
11.8.5 M Dialysis AB Recent Development
11.9 Thermo Fisher Scientific Inc
11.9.1 Thermo Fisher Scientific Inc Company Details
11.9.2 Thermo Fisher Scientific Inc Business Overview
11.9.3 Thermo Fisher Scientific Inc Fluidics for Preclinical Introduction
11.9.4 Thermo Fisher Scientific Inc Revenue in Fluidics for Preclinical Business (2015-2020)
11.9.5 Thermo Fisher Scientific Inc Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Fluidics for Preclinical Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Software and Accessories
Table 3. Key Players of Precision Syringe Pumps
Table 4. Global Fluidics for Preclinical Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Fluidics for Preclinical Market Size by Regions (US$ Million): 2020 VS 2026
Table 6. Global Fluidics for Preclinical Market Size by Regions (2015-2020) (US$ Million)
Table 7. Global Fluidics for Preclinical Market Share by Regions (2015-2020)
Table 8. Global Fluidics for Preclinical Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 9. Global Fluidics for Preclinical Market Share by Regions (2021-2026)
Table 10. Fluidics for Preclinical Market Market Trends
Table 11. Fluidics for Preclinical Market Drivers
Table 12. Fluidics for Preclinical Market Challenges
Table 13. Fluidics for Preclinical Market Restraints
Table 14. Global Fluidics for Preclinical Revenue by Players (2015-2020) (US$ Million)
Table 15. Global Fluidics for Preclinical Market Share by Players (2015-2020)
Table 16. Global Top Fluidics for Preclinical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fluidics for Preclinical as of 2019)
Table 17. Global Fluidics for Preclinical by Players Market Concentration Ratio (CR5 and HHI)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Fluidics for Preclinical Product Solution and Service
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Fluidics for Preclinical Market Size by Type (2015-2020) (US$ Million)
Table 22. Global Fluidics for Preclinical Revenue Market Share by Type (2015-2020)
Table 23. Global Fluidics for Preclinical Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 24. Global Fluidics for Preclinical Market Size Share by Application (2015-2020) (US$ Million)
Table 25. Global Fluidics for Preclinical Revenue Market Share by Application (2015-2020)
Table 26. Global Fluidics for Preclinical Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 27. North America Fluidics for Preclinical Market Size by Type (2015-2020) (US$ Million)
Table 28. North America Fluidics for Preclinical Market Share by Type (2015-2020)
Table 29. North America Fluidics for Preclinical Market Size by Application (2015-2020) (US$ Million)
Table 30. North America Fluidics for Preclinical Market Share by Application (2015-2020)
Table 31. North America Fluidics for Preclinical Market Size by Country (US$ Million) (2015-2020)
Table 32. North America Fluidics for Preclinical Market Share by Country (2015-2020)
Table 33. Europe Fluidics for Preclinical Market Size by Type (2015-2020) (US$ Million)
Table 34. Europe Fluidics for Preclinical Market Share by Type (2015-2020)
Table 35. Europe Fluidics for Preclinical Market Size by Application (2015-2020) (US$ Million)
Table 36. Europe Fluidics for Preclinical Market Share by Application (2015-2020)
Table 37. Europe Fluidics for Preclinical Market Size by Country (US$ Million) (2015-2020)
Table 38. Europe Fluidics for Preclinical Market Share by Country (2015-2020)
Table 39. Asia-Pacific Fluidics for Preclinical Market Size by Type (2015-2020) (US$ Million)
Table 40. Asia-Pacific Fluidics for Preclinical Market Share by Type (2015-2020)
Table 41. Asia-Pacific Fluidics for Preclinical Market Size by Application (2015-2020) (US$ Million)
Table 42. Asia-Pacific Fluidics for Preclinical Market Share by Application (2015-2020)
Table 43. Asia-Pacific Fluidics for Preclinical Market Size by Region (US$ Million) (2015-2020)
Table 44. Asia-Pacific Fluidics for Preclinical Market Share by Region (2015-2020)
Table 45. Latin America Fluidics for Preclinical Market Size by Type (2015-2020) (US$ Million)
Table 46. Latin America Fluidics for Preclinical Market Share by Type (2015-2020)
Table 47. Latin America Fluidics for Preclinical Market Size by Application (2015-2020) (US$ Million)
Table 48. Latin America Fluidics for Preclinical Market Share by Application (2015-2020)
Table 49. Latin America Fluidics for Preclinical Market Size by Country (US$ Million) (2015-2020)
Table 50. Latin America Fluidics for Preclinical Market Share by Country (2015-2020)
Table 51. Middle East & Africa Fluidics for Preclinical Market Size by Type (2015-2020) (US$ Million)
Table 52. Middle East & Africa Fluidics for Preclinical Market Share by Type (2015-2020)
Table 53. Middle East & Africa Fluidics for Preclinical Market Size by Application (2015-2020) (US$ Million)
Table 54. Middle East & Africa Fluidics for Preclinical Market Share by Application (2015-2020)
Table 55. Middle East & Africa Fluidics for Preclinical Market Size by Country (US$ Million) (2015-2020)
Table 56. Middle East & Africa Fluidics for Preclinical Market Share by Country (2015-2020)
Table 57. AMETEK Inc Company Details
Table 58. AMETEK Inc Business Overview
Table 59. AMETEK Inc Fluidics for Preclinical Product
Table 60. AMETEK Inc Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 61. AMETEK Inc Recent Development
Table 62. Blacktrace Holdings Ltd Company Details
Table 63. Blacktrace Holdings Ltd Business Overview
Table 64. Blacktrace Holdings Ltd Fluidics for Preclinical Product
Table 65. Blacktrace Holdings Ltd Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 66. Blacktrace Holdings Ltd Recent Development
Table 67. Fluigent SA Company Details
Table 68. Fluigent SA Business Overview
Table 69. Fluigent SA Fluidics for Preclinical Product
Table 70. Fluigent SA Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 71. Fluigent SA Recent Development
Table 72. Halma Plc Company Details
Table 73. Halma Plc Business Overview
Table 74. Halma Plc Fluidics for Preclinical Product
Table 75. Halma Plc Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 76. Halma Plc Recent Development
Table 77. Harvard Bioscience Inc Company Details
Table 78. Harvard Bioscience Inc Business Overview
Table 79. Harvard Bioscience Inc Fluidics for Preclinical Product
Table 80. Harvard Bioscience Inc Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 81. Harvard Bioscience Inc Recent Development
Table 82. IDEX Corp Company Details
Table 83. IDEX Corp Business Overview
Table 84. IDEX Corp Fluidics for Preclinical Product
Table 85. IDEX Corp Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 86. IDEX Corp Recent Development
Table 87. IMI Plc Company Details
Table 88. IMI Plc Business Overview
Table 89. IMI Plc Fluidics for Preclinical Product
Table 90. IMI Plc Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 91. IMI Plc Recent Development
Table 92. M Dialysis AB Business Overview
Table 93. M Dialysis AB Fluidics for Preclinical Product
Table 94. M Dialysis AB Company Details
Table 95. M Dialysis AB Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 96. M Dialysis AB Recent Development
Table 97. Thermo Fisher Scientific Inc Company Details
Table 98. Thermo Fisher Scientific Inc Business Overview
Table 99. Thermo Fisher Scientific Inc Fluidics for Preclinical Product
Table 100. Thermo Fisher Scientific Inc Revenue in Fluidics for Preclinical Business (2015-2020) (US$ Million)
Table 101. Thermo Fisher Scientific Inc Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Fluidics for Preclinical Market Share by Type: 2020 VS 2026
Figure 2. Software and Accessories Features
Figure 3. Precision Syringe Pumps Features
Figure 4. Global Fluidics for Preclinical Market Share by Application: 2020 VS 2026
Figure 5. Clinica Case Studies
Figure 6. Research Case Studies
Figure 7. Fluidics for Preclinical Report Years Considered
Figure 8. Global Fluidics for Preclinical Market Size (US$ Million), YoY Growth 2015-2026
Figure 9. Global Fluidics for Preclinical Market Share by Regions: 2020 VS 2026
Figure 10. Global Fluidics for Preclinical Market Share by Regions (2021-2026)
Figure 11. Global Fluidics for Preclinical Market Share by Players in 2019
Figure 12. Global Top Fluidics for Preclinical Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fluidics for Preclinical as of 2019
Figure 13. The Top 10 and 5 Players Market Share by Fluidics for Preclinical Revenue in 2019
Figure 14. North America Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 15. United States Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. Canada Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Europe Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Germany Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. France Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. U.K. Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Italy Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Russia Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Nordic Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Asia-Pacific Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. China Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Japan Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. South Korea Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Southeast Asia Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. India Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Australia Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Rest of Asia-Pacific Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Latin America Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Mexico Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Brazil Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Middle East & Africa Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Turkey Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Saudi Arabia Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. UAE Fluidics for Preclinical Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. AMETEK Inc Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 40. Blacktrace Holdings Ltd Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 41. Fluigent SA Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 42. Halma Plc Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 43. Harvard Bioscience Inc Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 44. IDEX Corp Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 45. IMI Plc Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 46. M Dialysis AB Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 47. Thermo Fisher Scientific Inc Revenue Growth Rate in Fluidics for Preclinical Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed